Proinflammatory cytokine TNF-α increases the stability of hepatitis B virus X protein through NF-κB signaling

Carcinogenesis

Volumn 32, Issue 7, 2011, Pages 978-985

  Shukla, Ruchi ^a,b   Yue, Jiping ^a   Siouda, Maha ^a   Gheit, Tarik ^a   Hantz, Olivier ^b   Merle, Philippe ^b,c   Zoulim, Fabien ^b,c,d,e   Krutovskikh, Vladimir ^a   Tommasino, Massimo ^a   Sylla, Bakary S ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^c HÔTEL DIEU   (France)

^d UNIVERSITÉ LYON 1   (France)

^e HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

EID: 79960040702     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr057     Document Type: Article

References (50)

1. Ferlay,J. et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917.
2. Kamangar,F. et al. (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol., 24, 2137-2150.
3. Dvorchik,I. et al. (2007) Prognostic models in hepatocellular carcinoma (HCC) and statistical methodologies behind them. Curr. Pharm. Des., 13, 1527-1532.
4. Lupberger,J. et al. (2007) Hepatitis B virus-induced oncogenesis. World J. Gastroenterol., 13, 74-81.
5. Gurtsevitch,V.E. (2008) Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry (Mosc.), 73, 504-513.
6. Feitelson,M.A. et al. (2007) Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett., 252, 157-170.
7. Kim,C.M. et al. (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature, 351, 317-320.
8. Diamantis,I.D. et al. (1992) Hepatitis B X-gene expression in hepatocellular carcinoma. J. Hepatol., 15, 400-403.
9. Andrisani,O.M. et al. (1999) The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis (Review). Int. J. Oncol., 15, 373-379.
10. Ahn,J.Y. et al. (2002) Dual effects of hepatitis B virus X protein on the regulation of cell-cycle control depending on the status of cellular p53. J. Gen. Virol., 83, 2765-2772.
11. Hu,Z. et al. (1999) Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J. Virol., 73, 7231-7240.
12. Kim,A. et al. (2008) Caspase-3 activation as a key factor for HBx-transformed cell death. Cell Prolif., 41, 755-774.
13. Yu,F.L. et al. (2005) Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3. J. Hepatol., 42, 520-527.
14. Livezey,K.W. et al. (2002) Increased chromosomal alterations and micronuclei formation in human hepatoma HepG2 cells transfected with the hepatitis B virus HBX gene. Mutat. Res., 505, 63-74.
15. Tang,H. et al. (2006) Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci., 97, 977-983.
16. Caselmann,W.H. (1995) Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis. J. Hepatol., 22, 34-37.
17. Elmore,L.W. et al. (1997) Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc. Natl Acad. Sci. USA, 94, 14707-14712.
18. Lin,Y. et al. (1997) The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct. Cancer Res., 57, 5137-5142.
19. Choi,B.H. et al. (1999) Interaction of hepatitis B viral X protein and CCAAT/ enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter. J. Biol. Chem., 274, 2858-2865.
20. Tanaka,Y. et al. (2006) The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Oncogene, 25, 633-642.
21. Seto,E. et al. (1990) Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature, 344, 72-74.
22. Lee,D.K. et al. (2001) The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev., 15, 455-466.
23. Waris,G. et al. (2001) Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol. Cell. Biol., 21, 7721-7730.
24. Su,F. et al. (1996) Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of relrelated proteins. J. Virol., 70, 4558-4566.
25. Weil,R. et al. (1999) Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha. Mol. Cell. Biol., 19, 6345-6354.
26. Kim,J.Y. et al. (2010) HBx-Induced hepatic steatosis and apoptosis are regulated by TNFR1- and NF-kappaB-dependent pathways. J. Mol. Biol., 397, 917-931.
27. Kim,H.R. et al. (2010) The hepatitis B viral X protein activates NF-kappaB signaling pathway through the up-regulation of TBK1. FEBS Lett., 584, 525-530.
28. Vallabhapurapu,S. et al. (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol., 27, 693-733.
29. Chen,F. et al. (1999) New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin. Chem., 45, 7-17.
30. Guo,S.P. et al. (2001) Expression of nuclear factor-kappa B in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus. World J. Gastroenterol., 7, 340-344.
31. Chan,C.F. et al. (2004) Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. Clin. Cancer Res., 10, 4140-4149.
32. Wang,T. et al. (2004) Activating mechanism of transcriptor NF-kappaB regulated by hepatitis B virus X protein in hepatocellular carcinoma. World J. Gastroenterol., 10, 356-360.
33. Chen,F. et al. (2008) Tumor promoting or tumor suppressing of NF-kappa B, a matter of cell context dependency. Int. Rev. Immunol., 27, 183-204.
34. Park,S.G. et al. (2009) Tumor suppressor protein p53 induces degradation of the oncogenic protein HBx. Cancer Lett., 282, 229-237.
35. Pang,R. et al. (2007) Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology, 132, 1088-1103.
36. Sakurai,H. et al. (1999) IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem., 274, 30353-30356.
37. Berasain,C. et al. (2009) Inflammation and liver cancer: new molecular links. Ann. N. Y. Acad. Sci., 1155, 206-221.
38. Wong,V.W. et al. (2009) High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int. J. Cancer, 124, 2766-2770.
39. Bui-Nguyen,T.M. et al. (2010) NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx. Oncogene, 29, 1179-1189.
40. Sakurai,H. et al. (2003) Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p.65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem., 278, 36916-36923.
41. Zheng,Y. et al. (2007) Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology, 363, 454-461.
42. Kim,J.H. et al. (2008) Ubiquitin-dependent and -independent proteasomal degradation of hepatitis B virus X protein. Biochem. Biophys. Res. Commun., 366, 1036-1042.
43. Xian,L. et al. (2010) p.53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2. Mol. Biol. Rep., 37, 2935-2940.
44. Ling,M.T. et al. (2008) Id-1 induces proteasome-dependent degradation of the HBX protein. J. Mol. Biol., 382, 34-43.
45. Bergametti,F. et al. (2002) Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex. J. Virol., 76, 6495-6501.
46. Dahlman,J.M. et al. (2009) The RelA/p.65 subunit of NF-kappaB specifically regulates cyclin D1 protein stability: implications for cell cycle withdrawal and skeletal myogenesis. J. Cell. Biochem., 106, 42-51.
47. Scott,M.L. et al. (1993) The p.65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev., 7, 1266-1276.
48. Bouchard,M.J. et al. (2006) Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. J. Virol., 80, 4406-4414.
49. Kim,W.H. et al. (2001) Additive activation of hepatic NF-kappaB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF-alpha receptor 1-independent and -dependent mechanisms. FASEB J., 15, 2551-2553.
50. Li,S. et al. (2009) Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients. Clin. Rheumatol., 28, 787-791.